Riskpilot← Back to searchSign inGet full accessRADFORSK INVESTERINGSSTIFTELSE
STIActiveOrg 952715704Ullernchausséen 64, 0379 OsloActivities of other membership organisations n.e.c. · NACE 9499Est. 19865 employeeswww.radforsk.no
Revenue 2024
NOK 5,4M
+26% vs 2023
EBITDA margin
-210.7%
+22% vs 2023
Equity ratio
69.2%
Financial strength
Net profit 2024
NOK -615,7M
-238% vs 2023
| Revenue | NOK 5,4M | +26% |
| EBITDA | NOK -11,3M | +22% |
| Net profit | NOK -615,7M | -238% |
| Total assets | NOK 118M | -86% |
| Equity | NOK 81,7M | -88% |
| Employees | 5 | — |
Legal name
RADFORSK INVESTERINGSSTIFTELSE
Org number
952715704
Legal form
Stiftelse
NACE code
9499 · Activities of other membership organisations n.e.c.
Founded
6. november 1986
Share capital
—
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Å fremme kreftforskningen, og gjennom sitt virke bidra til at det oppnås bedre og mer effektiv diagnose, behandling, pleie og forebygging av kreftsykdommene. Stiftelsen skal selv, eller gjennom direkte eller indirekte eierskap i andre forskningsbaserte selskaper eller sammenslutninger og øvrige investeringer, bidra til at det oppnås en bedre og mer effektiv diagnose, behandling, pleie og forebygging av kreftsykdommene. Stiftelsen skal også finansiere forskning, tilby undervisning, formidle informasjon og yte rådgivning samt bidra til å styrke det faglige miljøet på kreftforskning generelt, og på oslo universitetssykehus hf spesielt.
Address
Ullernchausséen 64, 0379 Oslo
Website
www.radforsk.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 431 | 6 697 | 7 447 | 4 252 | 5 374 |
| Staff expenses | −9 030 | −19 595 | −8 757 | −10 523 | −10 555 |
| EBITDA | −10 350 | −19 874 | −10 751 | −14 508 | −11 325 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −10 350 | −19 874 | −10 751 | −14 508 | −11 325 |
| Net financials | 5 909 | −2 038 | 600 312 | −167 484 | −604 325 |
| Profit before tax | −4 441 | −21 912 | 589 561 | −181 992 | −615 650 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −4 441 | −21 912 | 589 561 | −181 992 | −615 650 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 392 974 | 386 393 | 1 012 759 | 849 040 | 117 976 |
| Equity | 311 686 | 289 776 | 879 338 | 697 347 | 81 697 |
| Long-term debt | 50 420 | 68 000 | 109 313 | 125 920 | 21 934 |
| Short-term debt | 30 868 | 28 617 | 24 108 | 25 774 | 14 345 |
| Total debt | 81 288 | 96 617 | 133 421 | 151 693 | 36 279 |
EBITDA margin
-210.7%
This company
15.8%
Market median
-1434% vs market
20202024
Equity ratio
69.2%
This company
38.2%
Market median
+81% vs market
20202024
Return on equity
-753.6%
This company
18.4%
Market median
-4196% vs market
20202024
Net profit margin
-11456.1%
This company
8.1%
Market median
-141533% vs market
20202024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20202024
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JE Chief Executive Officer | Chief Executive Officer | 2003 |
| Former (1) | ||
JE Chief Executive Officer | Chief Executive Officer | 2003 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Board of Directors | 2010 | |
| Board of Directors | 2010 | |
| Chairman | 2025 | |
| Former (3) | ||
| Chairman | 2010 – 2025 | |
| Board of Directors | 2010 – 2025 | |
| Board of Directors | 2010 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
RADFORSK INVESTERINGSSTIFTELSE (this company)
BIOMOLEX ASBoard members of RADFORSK INVESTERINGSSTIFTELSE also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jonas Einarsson | Chief Executive Officer | 0 companies |
| Jónas Einarsson | Chief Executive Officer | 0 companies |
| Atle Brynestad | Chairman | 0 companies |
| Bente-Lill Bjerkelund Romøren | Board of Directors | 0 companies |
| Ingar Pettersen | Board of Directors | 0 companies |
| Jørgen Jansen | Board of Directors | 0 companies |
| Anne Merete Sveaass | Board of Directors | 0 companies |
| Erlend Bremertun Smeland | Board of Directors | 0 companies |
| Inger Sandlie | Board of Directors | 0 companies |
| Hanne Gaaserød | Chairman | 0 companies |